PL2513085T3 - Związki dwupierścieniowe jako ligandy receptora nikotynowego alfa4beta2 acetylocholiny - Google Patents

Związki dwupierścieniowe jako ligandy receptora nikotynowego alfa4beta2 acetylocholiny

Info

Publication number
PL2513085T3
PL2513085T3 PL09818648T PL09818648T PL2513085T3 PL 2513085 T3 PL2513085 T3 PL 2513085T3 PL 09818648 T PL09818648 T PL 09818648T PL 09818648 T PL09818648 T PL 09818648T PL 2513085 T3 PL2513085 T3 PL 2513085T3
Authority
PL
Poland
Prior art keywords
acetylcholine receptor
receptor ligands
nicotinic acetylcholine
bicyclic compounds
bicyclic
Prior art date
Application number
PL09818648T
Other languages
English (en)
Inventor
Ramakrishna Nirogi
Abdul Rasheed Mohammed
Srinivas Veeramalla
Srinivasa Rao Ravella
Ishtiyaque Ahmad
Pradeep Jayarajan
Anil Karbhari Shinde
Rama Sastri Kambhampti
Gopinadh Bhyrapuneni
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Limited filed Critical Suven Life Sciences Limited
Publication of PL2513085T3 publication Critical patent/PL2513085T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL09818648T 2009-11-18 2009-12-31 Związki dwupierścieniowe jako ligandy receptora nikotynowego alfa4beta2 acetylocholiny PL2513085T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2838CH2009 2009-11-18

Publications (1)

Publication Number Publication Date
PL2513085T3 true PL2513085T3 (pl) 2017-09-29

Family

ID=42228992

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09818648T PL2513085T3 (pl) 2009-11-18 2009-12-31 Związki dwupierścieniowe jako ligandy receptora nikotynowego alfa4beta2 acetylocholiny

Country Status (23)

Country Link
US (1) US8735423B2 (pl)
EP (1) EP2513085B1 (pl)
JP (1) JP5536227B2 (pl)
KR (1) KR101376145B1 (pl)
CN (1) CN102741239B (pl)
CA (1) CA2773409C (pl)
CY (1) CY1118361T1 (pl)
DK (1) DK2513085T3 (pl)
EA (1) EA020506B1 (pl)
ES (1) ES2601905T3 (pl)
HR (1) HRP20161461T1 (pl)
HU (1) HUE033352T2 (pl)
IL (1) IL219637A (pl)
LT (1) LT2513085T (pl)
MX (1) MX2012005637A (pl)
NZ (1) NZ600536A (pl)
PL (1) PL2513085T3 (pl)
PT (1) PT2513085T (pl)
RS (1) RS55469B1 (pl)
SI (1) SI2513085T1 (pl)
SM (1) SMT201600444B (pl)
WO (1) WO2011061751A1 (pl)
ZA (1) ZA201203522B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012271024B2 (en) * 2011-06-17 2015-07-09 Eli Lilly And Company Bicyclo (3.1.0) hexane- 2, 6 -dicarboxylic acid derivatives as mGlu2 receptor agonist
JP6103240B2 (ja) 2013-11-18 2017-03-29 トヨタ紡織株式会社 ピッチ材料の調整方法及び調整装置
EP3634408B1 (en) 2017-06-09 2022-12-28 Merck Sharp & Dohme LLC Azabicyclo[4.1.0]heptane allosteric modulators of the m4 muscarinic acetylcholine receptor
KR20240132502A (ko) 2022-01-11 2024-09-03 수벤 라이프 사이언시스 리미티드 헤테로지환형 유도체 및 이의 cns 장애의 치료에서의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337341A (en) * 1976-11-02 1982-06-29 Eli Lilly And Company 4a-Aryl-octahydro-1H-2-pyrindines
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
AU7871498A (en) * 1996-12-20 1998-07-17 Novo Nordisk A/S A method of treating hypercholesterolemia and related disorders
EP1189612A4 (en) * 1999-06-30 2005-02-16 Daiichi Seiyaku Co VLA-4 INHIBITABLE COMPOUNDS
JP2004534026A (ja) 2001-05-05 2004-11-11 スミスクライン ビーチャム パブリック リミテッド カンパニー オレキシン受容体アンタゴニストとしてのn−アロイルサイクリックアミン誘導体
FR2889187B1 (fr) * 2005-07-28 2007-09-07 Servier Lab Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI454262B (zh) 2006-11-02 2014-10-01 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺

Also Published As

Publication number Publication date
IL219637A0 (en) 2012-07-31
KR101376145B1 (ko) 2014-03-19
EP2513085B1 (en) 2016-09-28
EA201290344A1 (ru) 2012-10-30
AU2009355487B2 (en) 2013-10-10
EP2513085A1 (en) 2012-10-24
JP2013510901A (ja) 2013-03-28
MX2012005637A (es) 2012-06-13
SI2513085T1 (sl) 2017-02-28
EA020506B1 (ru) 2014-11-28
NZ600536A (en) 2013-05-31
CN102741239B (zh) 2015-06-24
HRP20161461T1 (hr) 2017-01-27
KR20120049943A (ko) 2012-05-17
RS55469B1 (sr) 2017-04-28
ES2601905T3 (es) 2017-02-16
CY1118361T1 (el) 2017-06-28
CA2773409A1 (en) 2011-05-26
IL219637A (en) 2015-10-29
PT2513085T (pt) 2016-11-14
CN102741239A (zh) 2012-10-17
HK1175782A1 (en) 2013-07-12
LT2513085T (lt) 2016-12-27
ZA201203522B (en) 2013-01-31
JP5536227B2 (ja) 2014-07-02
AU2009355487A1 (en) 2012-05-31
DK2513085T3 (en) 2016-12-05
HUE033352T2 (en) 2017-11-28
AU2009355487A8 (en) 2012-07-12
CA2773409C (en) 2015-06-16
US8735423B2 (en) 2014-05-27
US20130072518A1 (en) 2013-03-21
WO2011061751A1 (en) 2011-05-26
SMT201600444B (it) 2017-01-10

Similar Documents

Publication Publication Date Title
ZA201007527B (en) Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
IL213690A0 (en) Novel bicyclic heterocyclic compound
EP2351743A4 (en) BICYCLIC COMPOUND
IL218641A0 (en) Process for preparing azabicyclic compounds
EP2464650A4 (en) PROCESSES FOR PREPARING PEMETREXED
IL209727A0 (en) Pyridine compounds
ZA201201635B (en) Novel bicyclic urea compounds
ZA201102113B (en) Morphinan compounds
ZA201202703B (en) Synthetic methods for spiro-oxindole compounds
ZA201204063B (en) 2-pyridone compounds
ZA201204562B (en) 4b2 neuronal nicotinic acetylcholine receptor ligands
ZA201106221B (en) Bicyclic heterocyclic spiro compounds
IL208060A0 (en) Bicyclic pyrrole compound
ZA201005341B (en) Methods for inhibiting angiogenesis using egfl8 antagonists
IL219366A0 (en) Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
ZA201200956B (en) Novel tetrahydroisoquinoline compounds
IL219637A (en) Bicyclic compounds such as ligands for the 2ß4a nicotinic acetylcholine receptor
ZA201301143B (en) Heterocyclyl compounds as histamine h3 receptor ligands
IL209817A0 (en) Methods of preparing imidazole-based bicyclic compounds
ZA201100805B (en) Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
TH106311B (th) สารประกอบควินูคลีดีนในฐานะเป็นลิแกนด์ของตัวรับแอลฟา-7 นิโคทินิค แอเซทิลโคลีน
TH1201002302B (th) สารประกอบไบไซคลิกในฐานะเป็นลิแกนด์ของตัวรับ อัลฟา4 เบตา2 นิโคทินิกแอซีทิลโคลีน
HK1168855A (zh) 奎寧環化合物為α-7菸鹼型乙酰膽鹼受體配體
TWM372255U (en) Decoration structure for pillar
IL214295A0 (en) Bicyclic heterocyclic spiro compounds